Quoin Pharmaceuticals (QNRX) Non-Current Debt (2020 - 2022)
Quoin Pharmaceuticals (QNRX) posted Non-Current Debt of $3.5 million for Q4 2022, down 14.55% sequentially from $4.1 million in Q4 2021, and down 14.55% YoY from $4.1 million in Q4 2021.
Quoin Pharmaceuticals (QNRX) Non-Current Debt (2020 - 2022) Analysis & Trends
Quoin Pharmaceuticals has reported Non-Current Debt for 3 years, with the latest figure at $3.5 million in Q4 2022.
- Quarterly Non-Current Debt fell 14.55% year-over-year to $3.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $3.5 million (down 14.55% YoY) and the FY2022 annual result came in at $3.5 million, down 14.55% from the prior year.
- Non-Current Debt declined to $3.5 million in Q4 2022 per QNRX's latest filing, from $4.1 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $4.1 million in Q4 2021 and troughed at $1.2 million in Q4 2020.
- A 3-year average of $3.0 million and a median of $3.5 million in 2022 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2021 and 2022: Non-Current Debt jumped 239.87% in 2021, then slipped 14.55% in 2022.
- Over 3 years, Non-Current Debt stood at $1.2 million in 2020, then surged by 239.87% to $4.1 million in 2021, then retreated by 14.55% to $3.5 million in 2022.
- According to Business Quant data, Non-Current Debt over the past three periods registered $3.5 million, $4.1 million, and $1.2 million for Q4 2022, Q4 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.52 Mn |
| Dec 31, 2021 | 4.12 Mn |
| Dec 31, 2020 | 1.21 Mn |